CoChat
Sign Up
Cited by 57

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Mitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitis

Schröder, Torsten, Kucharczyk, David, Bär, Florian, Pagel, René, Derer, Stefanie, Jendrek, Sebastian Torben, Sünderhauf, Annika, Brethack, Ann-Kathrin, Hirose, Misa, Möller, Steffen, Künstner, Axel, Bischof, Julia, Weyers, Imke, Heeren, Jörg, Koczan, Dirk, Schmid, Sebastian Michael, Divanovic, Senad, Giles, Daniel Aaron, Adamski, Jerzy, Fellermann, Klaus, Lehnert, Hendrik, Köhl, Jörg, Ibrahim, Saleh, Sina, Christian·2016·Molecular Metabolism
DOI 10.1016/j.molmet.2016.01.010PMC PMC4812012
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.molmet.2016.01.010

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 54

  1. Williams, 2011, Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study, Gastroenterology, 140, 124, 10.1053/j.gastro.2010.09.038 · DOI
  2. Ratziua, 2010, A position statement on NAFLD/NASH based on the EASL 2009 special conference, Journal of Hepatology, 53, 372, 10.1016/j.jhep.2010.04.008 · DOI
  3. Adams, 2005, The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies, Journal of Hepatology, 42, 132, 10.1016/j.jhep.2004.09.012 · DOI
  4. Neuschwander-Tetri, 2003, Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference, Hepatology, 37, 1202, 10.1053/jhep.2003.50193 · DOI
  5. Rolo, 2012, Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis, Free Radical Biology & Medicine, 52, 59, 10.1016/j.freeradbiomed.2011.10.003 · DOI · Paper page
  6. Schuppan, 2013, Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches, Journal of Gastroenterology and Hepatology, 28, 68, 10.1111/jgh.12212 · DOI · Paper page
  7. Alexander, 2013, Nonalcoholic fatty liver disease contributes to hepatocellular carcinoma in non-cirrhotic liver: a clinical and pathological study, Journal of Gastroenterology and Hepatology, 10.1111/jgh.12116 · DOI
  8. Adams, 2005, The natural history of nonalcoholic fatty liver disease: a population-based cohort study, Gastroenterology, 113, 10.1053/j.gastro.2005.04.014 · DOI · Paper page
  9. Goessling, 2008, Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease, Gastroenterology, 135, 1935, 10.1053/j.gastro.2008.09.018 · DOI
  10. Fracanzani, 2008, Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes, Hepatology (Baltimore, Md.), 48, 792, 10.1002/hep.22429 · DOI
  11. Fromenty, 2004, The ins and outs of mitochondrial dysfunction in NASH, Diabetes & Metabolism, 30, 121, 10.1016/S1262-3636(07)70098-8 · DOI
  12. Koliaki, 2015, Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis, Cell Metabolism, 21, 739, 10.1016/j.cmet.2015.04.004 · DOI · Paper page
  13. Serviddio, 2008, Mitochondrial involvement in non-alcoholic steatohepatitis, Molecular Aspects of Medicine, 29, 22, 10.1016/j.mam.2007.09.014 · DOI
  14. Garcia-Ruiz, 2013, Mitochondrial dysfunction in nonalcoholic fatty liver disease and insulin resistance: cause or consequence?, Free Radical Research, 10.3109/10715762.2013.830717 · DOI
  15. Wallace, 2013, Mitochondrial DNA genetics and the heteroplasmy conundrum in evolution and disease, Cold Spring Harbor Perspectives in Biology, a021220, 10.1101/cshperspect.a021220 · DOI
  16. Lu, 2012, Mitochondrial polymorphism 12361A>G is associated with nonalcoholic fatty liver disease, Translational Research: The Journal of Laboratory and Clinical Medicine, 159, 58, 10.1016/j.trsl.2011.10.011 · DOI
  17. Yu, 2009, Dissecting the effects of mtDNA variations on complex traits using mouse conplastic strains, Genome Research, 19, 159, 10.1101/gr.078865.108 · DOI · Paper page
  18. Yu, 2009, The mtDNA nt7778 G/T polymorphism affects autoimmune diseases and reproductive performance in the mouse, Human Molecular Genetics, 18, 4689, 10.1093/hmg/ddp432 · DOI · Paper page
  19. Weiss, 2012, The mitochondrial Atp8 mutation induces mitochondrial ROS generation, secretory dysfunction, and β-cell mass adaptation in conplastic B6-mtFVB mice, Endocrinology, 153, 4666, 10.1210/en.2012-1296 · DOI · Paper page
  20. Scheffler, 2012, Mitochondrial DNA polymorphisms specifically modify cerebral β-amyloid proteostasis Katja, Acta Neuropathologica, 124, 199, 10.1007/s00401-012-0980-x · DOI
  21. Klaunig, 1981, Mouse liver cell culture. II. Primary culture, In Vitro, 17, 926
  22. Bär, 2013, Mitochondrial gene polymorphisms that protect mice from colitis, Gastroenterology, 145, 10.1053/j.gastro.2013.07.015 · DOI
  23. Römisch-Margl, 2011, Procedure for tissue sample preparation and metabolite extraction for high-throughput targeted metabolomics, Metabolomics, 8, 133, 10.1007/s11306-011-0293-4 · DOI
  24. Illig, 2013, A genomewide perspective of genetic variation in human metabolism, Nature Genetics, 42, 137, 10.1038/ng.507 · DOI · Paper page
  25. Kleiner, 2005, Design and validation of a histological scoring system for nonalcoholic fatty liver disease, Hepatology (Baltimore, Md.), 41, 1313, 10.1002/hep.20701 · DOI · Paper page
  26. Murphy, 2009, How mitochondria produce reactive oxygen species, The Biochemical Journal, 417, 1, 10.1042/BJ20081386 · DOI · Paper page
  27. Albano, 2005, Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis, Gut, 54, 987, 10.1136/gut.2004.057968 · DOI · Paper page
  28. Hardie, 2003, Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status, Endocrinology, 144, 5179, 10.1210/en.2003-0982 · DOI · Paper page
  29. Lee, 2010, AMPK-dependent metabolic regulation by PPAR agonists, PPAR Research, 2010, 10.1155/2010/549101 · DOI
  30. Dumas, 2014, Metabolic phenotyping and systems biology approaches to understanding metabolic syndrome and fatty liver disease, Gastroenterology, 146, 46, 10.1053/j.gastro.2013.11.001 · DOI
  31. Fingerhut, 2001, Hepatic carnitine palmitoyltransferase I deficiency: acylcarnitine profiles in blood spots are highly specific, Clinical Chemistry, 47, 1763, 10.1093/clinchem/47.10.1763 · DOI
  32. Garcia-Caraballo, 2013, Prevention and reversal of hepatic steatosis with a high-protein diet in mice, Biochimica et Biophysica Acta – Molecular Basis of Disease, 1832, 685, 10.1016/j.bbadis.2013.02.003 · DOI
  33. Takahashi, 2012, Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis, World Journal of Gastroenterology: WJG, 18, 2300, 10.3748/wjg.v18.i19.2300 · DOI · Paper page
  34. Charlton, 2011, Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition, American Journal of Physiology. Gastrointestinal and Liver Physiology, 301, G825, 10.1152/ajpgi.00145.2011 · DOI
  35. Pessayre, 2007, Role of mitochondria in non-alcoholic fatty liver disease, Journal of Gastroenterology and Hepatology, 22, S20, 10.1111/j.1440-1746.2006.04640.x · DOI
  36. Begriche, 2013, Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease, Hepatology, 58, 1497, 10.1002/hep.26226 · DOI · Paper page
  37. Day, 1998, Steatohepatitis: a tale of two “hits”?, Gastroenterology, 114, 842, 10.1016/S0016-5085(98)70599-2 · DOI · Paper page
  38. Mantena, 2008, Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases, Free Radical Biology & Medicine, 44, 1259, 10.1016/j.freeradbiomed.2007.12.029 · DOI · Paper page
  39. Wallace, 1999, Mitochondrial diseases man and mouse, Science, 283, 1482, 10.1126/science.283.5407.1482 · DOI · Paper page
  40. Ren, 2010, Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease, Journal of Molecular Medicine (Berlin, Germany), 88, 993, 10.1007/s00109-010-0663-9 · DOI
  41. Auger, 2015, Dysfunctional mitochondrial bioenergetics and the pathogenesis of hepatic disorders, Frontiers in Cell and Developmental Biology, 3, 1, 10.3389/fcell.2015.00040 · DOI
  42. Tomita, 2006, Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice, Gut, 55, 415, 10.1136/gut.2005.071118 · DOI
  43. Ayonrinde, 2011, Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease, Hepatology, 53, 800, 10.1002/hep.24097 · DOI
  44. Albano, 2005, Review article: role of oxidative stress in the progression of non-alcoholic steatosis, Alimentary Pharmacology & Therapeutics, 22, 71, 10.1111/j.1365-2036.2005.02601.x · DOI
  45. Koliaki, 2013, Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease, Molecular and Cellular Endocrinology, 379, 35, 10.1016/j.mce.2013.06.002 · DOI
  46. Koves, 2008, Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance, Cell Metabolism, 7, 45, 10.1016/j.cmet.2007.10.013 · DOI · Paper page
  47. Hue, 2009, The Randle cycle revisited: a new head for an old hat, American Journal of Physiology. Endocrinology and Metabolism, 297, E578, 10.1152/ajpendo.00093.2009 · DOI · Paper page
  48. Mingorance, 2012, Propionyl-L-carnitine corrects metabolic and cardiovascular alterations in diet-induced obese mice and improves liver respiratory chain activity, PLoS One, 7, e34268, 10.1371/journal.pone.0034268 · DOI
  49. Betancourt, 2014, Mitochondrial-nuclear genome interactions in non-alcoholic fatty liver disease in mice, The Biochemical Journal, 461, 223, 10.1042/BJ20131433 · DOI
  50. Musso, 2013, Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis, Progress in Lipid Research, 52, 175, 10.1016/j.plipres.2012.11.002 · DOI
  51. Wong, 2013, Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis – a longitudinal study, PLoS One, 8, e62885, 10.1371/journal.pone.0062885 · DOI
  52. Mouzaki, 2013, Intestinal microbiota in patients with nonalcoholic fatty liver disease, Hepatology (Baltimore, Md.) (Im), 1
  53. Wieland, 2015, Systematic review: microbial dysbiosis and nonalcoholic fatty liver disease, Alimentary Pharmacology & Therapeutics, 42, 1051, 10.1111/apt.13376 · DOI
  54. Boursier, 2015, The severity of NAFLD is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota, Hepatology (Baltimore, Md.), 1

Cited by

Sorted by citations

Metadata

Authors
Schröder, T., Kucharczyk, D., Bär, F., Pagel, R., Derer, S., Jendrek, S. T., Sünderhauf, A., Brethack, A.-K., Hirose, M., Möller, S., Künstner, A., Bischof, J., Weyers, I., Heeren, J., Koczan, D., Schmid, S. M., Divanovic, S., Giles, D. A., Adamski, J., Fellermann, K., Lehnert, H., Köhl, J., Ibrahim, S., & Sina, C.
ORCID
Divanovic, Senad
Venue
Molecular Metabolism
Publisher
Elsevier BV
Published
2016-04
Volume
5
Issue
4
Pages
283-295
ISSN
2212-8778
DOI
10.1016/j.molmet.2016.01.010
PMC
PMC4812012
Cited by
57
References
6
Language
en
Licence
Funders
Deutsche Forschungsgemeinschaft (SFB 841)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review